• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 3. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 4. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 5. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acid esters
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzoic acid esters

Recent Advances in the Application of Methyl 2-amino-5-(trifluoromethyl)benzoate (CAS: 117324-58-0) in Chemical Biology and Pharmaceutical Research

Methyl 2-amino-5-(trifluoromethyl)benzoate (CAS: 117324-58-0) is a fluorinated aromatic compound that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound, characterized by the presence of a trifluoromethyl group and an ester functionality, serves as a key intermediate in the synthesis of various bioactive molecules. Recent studies have highlighted its potential in drug discovery, particularly in the development of novel therapeutic agents targeting inflammatory diseases, cancer, and infectious diseases.

One of the most notable advancements in the use of Methyl 2-amino-5-(trifluoromethyl)benzoate is its role in the synthesis of small-molecule inhibitors. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its utility in the design of potent inhibitors for protein kinases involved in cancer progression. The trifluoromethyl group was found to enhance the binding affinity of these inhibitors by forming favorable interactions with hydrophobic pockets in the target proteins. This discovery opens new avenues for the development of targeted therapies with improved efficacy and reduced off-target effects.

In addition to its applications in oncology, Methyl 2-amino-5-(trifluoromethyl)benzoate has also been explored as a building block for antimicrobial agents. A recent study in Bioorganic & Medicinal Chemistry Letters reported the synthesis of a series of derivatives exhibiting broad-spectrum activity against drug-resistant bacterial strains. The incorporation of the trifluoromethyl group was shown to improve the metabolic stability of these compounds, addressing a common challenge in antibiotic development. These findings underscore the potential of this compound in addressing the global threat of antimicrobial resistance.

Another area of active research involves the use of Methyl 2-amino-5-(trifluoromethyl)benzoate in the development of imaging probes for biomedical applications. Researchers have leveraged its unique physicochemical properties to design fluorescent and radiolabeled probes for real-time monitoring of biological processes. For instance, a 2022 study in Chemical Communications described the synthesis of a near-infrared fluorescent probe based on this compound, which was successfully used to visualize tumor margins during surgical procedures. Such innovations highlight the compound's versatility beyond traditional drug discovery.

Despite these promising developments, challenges remain in the large-scale synthesis and optimization of Methyl 2-amino-5-(trifluoromethyl)benzoate derivatives. Recent efforts have focused on improving synthetic routes to enhance yield and purity while minimizing environmental impact. Green chemistry approaches, such as catalytic trifluoromethylation and solvent-free reactions, are being explored to address these challenges. A 2023 review in Advanced Synthesis & Catalysis summarized these advancements, providing a roadmap for future research in this area.

In conclusion, Methyl 2-amino-5-(trifluoromethyl)benzoate (CAS: 117324-58-0) continues to be a valuable tool in chemical biology and pharmaceutical research. Its unique structural features enable the development of diverse bioactive molecules with potential applications in drug discovery, antimicrobial therapy, and biomedical imaging. Ongoing research efforts aim to further elucidate its mechanistic roles and optimize its derivatives for clinical translation. As the field advances, this compound is expected to play an increasingly important role in addressing unmet medical needs.

• 22235-25-2(Methyl 3-amino-5-(trifluoromethyl)benzoate)
• 167760-75-0(Methyl 4-amino-3-(trifluoromethyl)benzoate)
• 126541-82-0(Methyl 3-amino-4-(trifluoromethyl)benzoate)
• 147494-56-2(Methyl 2-amino-6-(trifluoromethyl)benzoate)
• 65568-55-0(Ethyl 2-amino-4-trifluoromethylbenzoate)
• 688020-69-1(ethyl 4-amino-3-(trifluoromethyl)benzoate)
• 1108668-05-8(Ethyl 2-amino-5-(trifluoromethyl)benzoate)
• 64321-95-5(Methyl 2-amino-3-(trifluoromethyl)benzoate)
• 872624-53-8(Methyl 2-amino-5-methyl-4-(trifluoromethyl)benzoate)
• 61500-87-6(Methyl 2-amino-4-(trifluoromethyl)benzoate)